AKIN GUMP STRAUSS HAUER & FELD for ABBOTT LABORATORIES
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2021 | $40,000 | Replaced |
| 4th Quarter - Amendment | Nov 3, 2022 | $40,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Strategic and policy advice related to U.S.-India trade relations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROGER MURRY | — |
Health Issues HCR
Strategic and policy advice related to healthcare issues; monitor developments related to COVID-19 stimulus legislation, telehealth, and appropriations issues related to healthcare testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LOUIS AGNELLO | — |
| BRENDAN DUNN | — |
| ARSHI SIDDIQUI | — |
Veterans VET
Appropriations issue related to healthcare testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDAN DUNN | — |
Medicare/Medicaid MMM
Strategic and policy advice related to Medicare and Medicaid issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDE BAJNRAUH | — |
Taxation/Internal Revenue Code TAX
Strategic and policy advice related to tax issues; Consolidated Appropriations Act, 2021 (H.R.133), including tax extenders and the CFC Look-through Rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDAN DUNN | — |
| ARSHI SIDDIQUI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.